Implantable drug delivery systems: An overview

Systematic Reviews in Pharmacy

Volumn 2, Issue 2, 2011, Pages 91-95

  Rajgor, N ^a   Patel, M ^b   Bhaskar, V H ^a  

^a MP Patel College of Pharmacy   (India)

^b NOOTAN PHARMACY COLLEGE   (India)

Author keywords

Biosensor; Implantable pump; Implantable rod; Polymers

Indexed keywords

CORTODOXONE; DOXORUBICIN; ESTRADIOL; HYDROMORPHONE; IBUPROFEN; INSULIN; MEGESTROL; MORPHINE; NAPROXEN; NORGESTREL; PHENYLBUTAZONE; PILOCARPINE; POLYASPARTIC ACID; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; PROGESTERONE DERIVATIVE;

BIODEGRADABLE IMPLANT; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG IMPLANTATION; EQUIPMENT DESIGN; IMPLANTABLE ROD; INFUSION PUMP; NON DEGRADABLE IMPLANT SYSTEM; OSMOTIC PUMP; PERISTALTIC PUMP; POSITIVE DISPLACEMENT PUMP; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 80155145247     PISSN: 09758453     EISSN: 09762779     Source Type: Journal    
DOI: 10.4103/0975-8453.86297     Document Type: Review

References (31)

1. Danckwerts M, Fassihi A. Implantable controlled release drug delivery systems: A Review. Drug Dev Ind Pharm 1991;17:1465-502.
2. Available from: http://www.pharmainfo.net/pppc06/implantable- drugdelivery-system. [Last accessed on 2010 Nov 1].
3. Costantini LC, Kleppner SR, McDonough J, Azar MR, Patel R. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism. Int J Pharm 2004;283:35-44. (Pubitemid 39200924)
4. Ranade V. Drug delivery systems Implants in drug delivery. J Clin Pharm 1990;30:871-89.
5. Baker R. Controlled Release of Biologically Active Agents. NewYork: John Wiley; 1987. p. 40-56.
6. Juni K, Ogata J, Nakano M, Ichihara T, Mori K, Akagi M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. Chem Pharm Bull 1985;33:313-8. (Pubitemid 15130860)
7. Alekha KD, Greggrey CC. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998;40:1-12.
8. Higuchi T. Rate of release of medicaments from ointment base containing drugs in suspension. J Pharm Sci 1961;50:874-879.
9. Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin M, Langer R, editors. Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker; 190. p. 1-41.
10. Wood DA. Biodegradable drug delivery systems. Int J Pharm 1980;7: 1-18. (Pubitemid 11135259)
11. Zaheer S, Lehman J, Stevenson G. Capsular contracture around silicone implants: The role of intraluminal antibiotics. Plast Reconstr Surg 1982;69:809-12.
12. Langer R. Implantable controlled release systems. In: Ihler GM, editor. Methods of Drug Delivery. New York: Pergamon Press; 1986. p. 121-37.
13. Graham NB. Polymeric inserts and implants for the controlled release of drugs. Br Polymer J 1978;10:260-6.
14. Wang X, Chen T, Yang Z, Wang W. Study on structural optimum design of implantable drug delivery micro-system. Simul Modelling Pract Theory 2007;15:47-56. (Pubitemid 46037569)
15. Sershenl S, West J. Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv Rev 2002;54:1225-35. (Pubitemid 35223419)
16. Kimura H, Ogura Y, Hashizoe M, Nishiwaki H, Honda Y, Ikada Y. A new vitreal drug delivery system using an implantable biodegradable polymeric device. Invest Ophthalmol Vis Sci 1994;35:2815-9. (Pubitemid 24149795)
17. Brown LR, Wei CL, Langer R. In vivo and in vitro release of macromolecules form polymeric drug delivery systems. J Pharm Sci 1983;72:1181-5. (Pubitemid 13013638)
18. Rhine W, Hsieh DS, Langer R. Polymers for sustained macromolecule release: Procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci 1980;69:265-70. (Pubitemid 10121421)
19. Barrera D, Zylstra E, Lansbury PT, Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer: Poly(lactic acid-colysine). J Am Chem Soc 1993;115:11010-1.
20. Dagani R. Biodegradable copolymer eyed as tissue matrix. Chem Eng News 1993;22:5-8.
21. Cao L, Mentell S, Polla D. Design and simulation of an implantable medical drug delivery system using microelectromechanical systems technology. Sens Actuators A Phys 2001;94:117-25. (Pubitemid 32997670)
22. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: The future for insulin pump therapy. Curr Opin Pharmacol 2002;2:708-16. (Pubitemid 35476924)
23. Blackshear PJ, Rhode TH. Artificial devices for insulin infusion in the treatment of patients with diabetes mellitus. In: Burk SD, editor. Controlled Drug Delivery, Clinical Applications. Vol 2. Boca Raton, FL: CRC Press; 1983. p. 11.
24. Dash AK, Suryanarayanan R. An implantable dosage form for the treatment of bone infections. Pharm Res 1992;9:993-1002.
25. Sefton MV. Implantable pumps. CRC Crit Rev Bioeng 1987;14:201-40.
26. Martin A, Bustamante P, Chun A. Physical pharmacy. In: Mundorff GH, editor. 4th ed. Malvern, PA: Lea and Febiger Press; 1993. p. 534-6.
27. Theeuwes F, Yum SI. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 1976;4:343-53.
28. Fara JW, Ray N. Osmotic pumps. In: Tyle P, editor. Drug Delivery Devices: Fundamentals and Applications. New York: Marcel Dekker; 1988: 1-41.
29. Lesser GJ, Grossman SA, Leong KW, Lo H, Eller S. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain 1996;65:265-72. (Pubitemid 26228044)
30. Blackshear PJ. Implantable drug-delivery systems. Sci Am 1979;241: 66-73.
31. Smith TJ, Coyne PJ. How to use implantable intrathecal drug delivery systems for refractory cancer pain. J Support Oncol 2003;1:73-6.